Literature DB >> 22132978

Characterization of oligomeric and kinetic properties of tomato thymidine kinase 1.

Zeeshan Mutahir1, Nicolai Balle Larsen, Louise Slot Christiansen, Karl-Magnus Andersson, Ricardo Rico, Sofia Mebrahtu Wisen, Anders Ranegaard Clausen, Birgitte Munch-Petersen, Jure Piškur.   

Abstract

The gene encoding thymidine kinase 1 from tomato (toTK1) has in combination with azidothymidine (AZT) recently been proposed as a powerful suicide gene for anticancer gene therapy. The toTK1/AZT combination has been demonstrated to have several advantages for the treatment of glioblastomas because AZT can easily penetrate the blood-brain barrier and toTK1 can efficiently phosphorylate AZT and also AZT-monophosphate. In a pursuit to further understand the properties of toTK1, we examined the oligomerization properties of recombinant toTK1 and its effect on enzyme kinetics. Previously, it has been shown that human TK1 is a dimer in the absence of ATP and a tetramer if preincubated with ATP. However, we show here that ATP preincubation did not result in a structural shift from dimer to tetramer in toTK1. For human TK1 pretreated with ATP, the K(m) value decreased 20-fold, but toTK1's K(m) value did not show a dependence on the presence or absence of ATP. Furthermore, toTK1 was always found in a highly active form.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22132978     DOI: 10.1080/15257770.2011.597629

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  2 in total

1.  Arabidopsis thaliana thymidine kinase 1a is ubiquitously expressed during development and contributes to confer tolerance to genotoxic stress.

Authors:  José Antonio Pedroza-García; Manuela Nájera-Martínez; María de la Paz Sanchez; Javier Plasencia
Journal:  Plant Mol Biol       Date:  2014-12-24       Impact factor: 4.076

2.  Tomato thymidine kinase-based suicide gene therapy for malignant glioma--an alternative for Herpes Simplex virus-1 thymidine kinase.

Authors:  H Stedt; H Samaranayake; J Kurkipuro; G Wirth; L S Christiansen; T Vuorio; A-M Määttä; J Piškur; S Ylä-Herttuala
Journal:  Cancer Gene Ther       Date:  2015-01-23       Impact factor: 5.987

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.